Skip to main content
. 2023 Jan 14;78(3):692–702. doi: 10.1093/jac/dkac446

Figure 5.

Figure 5.

Taniborbactam fAUC0–24/MIC required to achieve efficacy endpoints against Enterobacterales (n = 8) and P. aeruginosa (n = 4) when co-administered with the cefepime human-simulated regimen. Median values are displayed on the plots. Median 2 log kill target for Enterobacterales calculated based on seven isolates (target not achieved against one isolate). Hinges represent 25th and 75th percentiles. Whiskers represent 10th and 90th percentiles. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.